Filter
4270
Filtered Results: 4270
Text search:
trial
Featured
Recommendations
412
New Publications
825
Language
Document type
No document type
2272
Studies & Reports
726
Guidelines
694
Manuals
204
Fact sheets
136
Strategic & Response Plan
96
Training Material
53
Situation Updates
27
Resource Platforms
25
Infographics
17
Brochures
10
Videos
8
App
1
Online Courses
1
Countries / Regions
India
204
Global
175
South Africa
94
Kenya
77
Western and Central Europe
76
Africa
61
Ethiopia
58
Nigeria
56
Uganda
55
Sierra Leone
54
Liberia
51
Nepal
48
Malawi
48
Russia
47
Germany
41
Latin America and the Carribbean
39
Zambia
38
Eastern Europe
38
Bangladesh
37
Ukraine
37
Tanzania
35
Brazil
35
East and Southern Africa
33
West and Central Africa
32
Ghana
29
Indonesia
29
Rwanda
28
Asia
28
Philippines
27
Zimbabwe
26
Myanmar / Burma
26
South Sudan
25
Senegal
23
Syria
23
Mozambique
23
Guinea
22
Congo, Democratic Republic of
22
South–East Asia Region
22
Middle East and North Africa
21
Cambodia
20
Burkina Faso
19
Namibia
17
Lesotho
16
Paraguay
16
Venezuela
14
USA
13
Colombia
13
Cameroon
12
Haiti
12
Eastern Europe and Central Asia
12
Thailand
10
Central African Republic
9
Argentina
9
Eswatini/ Swaziland
9
China
8
Peru
8
Chile
8
Yemen
8
Vietnam
8
Mali
7
Sudan
7
Botswana
7
Angola
7
Guinea-Bissau
6
Jordan
6
Benin
6
Western Pacific Region
6
Albania
6
Laos
6
Tajikistan
6
Pakistan
5
Lebanon
5
Papua New Guinea
5
Bolivia
5
Southern Africa
5
Spain
5
Iraq
4
Kyrgyzstan
4
Georgia
4
North America
4
United Kingdom
4
Côte d’Ivoire / Ivory Coast
3
Morocco
3
Somalia
3
Afghanistan
3
Ecuador
3
Madagascar
3
Sri Lanka
3
Estonia
3
Iran
3
Turkey
2
Chad
2
Singapore
2
North Macedonia
2
Switzerland
2
Hungary
2
Croatia
2
Burundi
2
El Salvador
2
Greece
2
Mexico
2
Other region
2
Poland
2
Italy
2
Lithuania
2
Moldova
2
Kazakhstan
2
Jamaica
2
France
2
Tunisia
2
Portugal
2
Belarus
2
Saudi Arabia
1
Niger
1
Togo
1
Egypt
1
Gambia
1
Malaysia
1
Ireland
1
Serbia
1
Honduras
1
Guatemala
1
Bhutan
1
Armenia
1
Canada
1
Qatar
1
Bulgaria
1
Gabon
1
Japan
1
Denmark
1
Belgium
1
Norway
1
Authors & Publishers
Publication Years
Category
Countries
1216
Clinical Guidelines
474
Public Health
255
Women & Child Health
230
Key Resources
106
Capacity Building
48
Pharmacy & Technologies
42
Toolboxes
Mental Health
520
COVID-19
516
HIV
417
TB
322
NTDs
160
NCDs
129
Ebola
124
Caregiver
120
AMR
104
Planetary Health
99
Disability
89
Rapid Response
84
Pharmacy
79
Refugee
63
Conflict
59
Global Health Education
46
Health Financing Toolbox
28
Cholera
26
Natural Hazards
24
Zika
19
Polio
15
Social Ethics
15
Specific Hazards
13
Health Financing
2
A systematic review of randomized controlled efficacy trials | REPORT -
DEPARTMENT OF CHILD AND ADOLESCENT HEALTH AND DEVELOPMENT
Researchers are devising a clinical-trial protocol to test three medicines in Africa's latest outbreak
Nature doi: 10.1038/d41586-018-06132-7
The twentieth century ended with human African trypanosomiasis (HAT) epidemics raging across many parts of Africa. Resistance to existing drugs was emerging, and many programs aiming to contain the disease had ground to a halt, given previous success against HAT and the competing priorities associat...
WHO and UNITAID
in collaboration with IMPAACT (International Maternal Pediatric Adolescent AIDS Clinical Trials) network, PENTA (Paediatric European Network for Treatment of AIDS) foundation and experts from the Paediatric Antiretroviral Working Group
This document provides up-to-date guidance on laboratory studies as well as smallscale (semi-field) and large-scale field trials to assess the efficacy and determine field
application rates of new molluscicide products for control of schistosomiasis.
COVAXINTM, India's indigenous COVID-19 vaccine by Bharat Biotech is developed in collaboration with the Indian Council of Medical Research (ICMR) - National Institute of Virology (NIV). The indigenous, inactivated vaccine is developed and manufactured in Bharat Biotech's BSL-3 (Bio-Safety Level 3) h...
Phillips and colleagues have shown that rifampicin combined with clarithromycin is non-inferior to RS8, and is safer. This much anticipated trial provides us with a high degree of confidence that an 8-week course of oral rifampicin and clarithromycin should now be the cornerstone of the treatment of...
A wide spectrum of disease severity has been described for Human African Trypanosomiasis (HAT) due to
Trypanosoma brucei rhodesiense (T.b. rhodesiense), ranging from chronic disease patterns in southern countries of East Africa to an increase in virulence towards the north. However, only limited d...
This special issue on Newborn Health in Global Health Action is being launched to share the experience of how to scale up a cost-effective package of newborn care that involves families, community health workers and health facilities. The results of this community randomized trial, the Uganda Newbor...
The 2014–2015 Ebola epidemic in western Africa was the longest and most deadly Ebola epidemic in history, resulting in 28,616 cases and 11,310 deaths in Guinea, Liberia, and Sierra Leone. The Ebola virus has been known since 1976, when two separate outbreaks were identified in the Democratic Repub...
The COPSI project is divided into three phases: the first in which the intervention is developed, the second in which researchers evaluate the intervention in a randomised controlled trial, and the final one in which the results of the trial are analysed and disseminated.
A COPSI resource kit has ...
WHO recommends that pre-exposure prophylaxis (PrEP) be offered as an additional prevention choice for HIV-negative individuals at substantial risk of HIV infection as part of combination prevention approaches.
HIV drug resistance has been rarely reported among PrEP users who tested HIV positive i...
The method, entitled “elicit-provide-elicit”, is a patient centred method which is adaptable to a range of clinical situations. Recent clinical trials show that the introduction of advanced communication skills based on this method in general practice allows primary care physicians to prescribe...
COVID-19 vaccine tracker and landscape
recommended
The COVID-19 vaccine tracker and landscape compiles detailed information of each COVID-19 vaccine candidate in development by closely monitoring their progress through the pipeline.
The COVID-19 vaccine tracker:
Provides summary tables of COVID-19 vaccine candidates in both clinical and pre-...
Africa Centers for Disease Control and Prevention (Africa CDC) is aware of the media releases of the preliminary results of a large randomized clinical trial conducted in the United Kingdom, which included dexamethasone, a corticosteroid, as one of the drugs used for the treatment of COVID-19 patien...
As of 31 October 2020 This is the tenth edition of this summary of rapid systematic reviews, which includes the results of a rapid systematic review of currently available literature. More than 200 therapeutic options or their combinations are being investigated in more than 1,700 clinical trials. I...
This article is part two in a series of explainers on vaccine development and distribution. Part one focused on how vaccines work to protect our bodies from disease-carrying germs. This article focuses on the ingredients in a vaccine and the three clinical trial phases. Part three outlines the nex...
Exciting news this week with @Pfizer reporting their mRNA vaccine is 90% effective, based on their Phase III clinical trial data. Dr. Tom looks inside the virus to break down how mRNA vaccines work, and whether news this promising means we can finally relax.
This document is part three in a series of explainers on vaccine development and distribution. Part one focused on how vaccines work to protect our bodies from disease-carrying germs. Part two focused on the ingredients in a vaccine and the three clinical trial phases.
This document outlines the...
As of January 20, 2021 the Covid-19 - living NMA initiative collected 150 RCTs and 36 non-randomised studies of vaccines from the ICTRP. 93 of these trials are recruiting patients.
